117 related articles for article (PubMed ID: 16322335)
1. The p53-homologue p63 may promote thyroid cancer progression.
Malaguarnera R; Mandarino A; Mazzon E; Vella V; Gangemi P; Vancheri C; Vigneri P; Aloisi A; Vigneri R; Frasca F
Endocr Relat Cancer; 2005 Dec; 12(4):953-71. PubMed ID: 16322335
[TBL] [Abstract][Full Text] [Related]
2. DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development.
Wu G; Nomoto S; Hoque MO; Dracheva T; Osada M; Lee CC; Dong SM; Guo Z; Benoit N; Cohen Y; Rechthand P; Califano J; Moon CS; Ratovitski E; Jen J; Sidransky D; Trink B
Cancer Res; 2003 May; 63(10):2351-7. PubMed ID: 12750249
[TBL] [Abstract][Full Text] [Related]
3. HMGA1 inhibits the function of p53 family members in thyroid cancer cells.
Frasca F; Rustighi A; Malaguarnera R; Altamura S; Vigneri P; Del Sal G; Giancotti V; Pezzino V; Vigneri R; Manfioletti G
Cancer Res; 2006 Mar; 66(6):2980-9. PubMed ID: 16540646
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of p63 and p53 expression in tissue microarrays of malignant melanomas.
Brinck U; Ruschenburg I; Di Como CJ; Buschmann N; Betke H; Stachura J; Cordon-Cardo C; Korabiowska M
Int J Mol Med; 2002 Dec; 10(6):707-11. PubMed ID: 12429996
[TBL] [Abstract][Full Text] [Related]
5. p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation.
Okada Y; Osada M; Kurata S; Sato S; Aisaki K; Kageyama Y; Kihara K; Ikawa Y; Katoh I
Exp Cell Res; 2002 Jun; 276(2):194-200. PubMed ID: 12027449
[TBL] [Abstract][Full Text] [Related]
6. Differential recognition of response elements determines target gene specificity for p53 and p63.
Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
[TBL] [Abstract][Full Text] [Related]
7. p63 expression is associated with p53 loss in oral-esophageal epithelia of p53-deficient mice.
Suliman Y; Opitz OG; Avadhani A; Burns TC; El-Deiry W; Wong DT; Rustgi AK
Cancer Res; 2001 Sep; 61(17):6467-73. PubMed ID: 11522642
[TBL] [Abstract][Full Text] [Related]
8. Endogenous p63 acts as a survival factor for tumour cells of SCCHN origin.
Thurfjell N; Coates PJ; Vojtesek B; Benham-Motlagh P; Eisold M; Nylander K
Int J Mol Med; 2005 Dec; 16(6):1065-70. PubMed ID: 16273287
[TBL] [Abstract][Full Text] [Related]
9. P63 expression in papillary and anaplastic carcinomas of the thyroid gland: lack of an oncogenetic role in tumorigenesis and progression.
Preto A; Reis-Filho JS; Ricardo S; Soares P
Pathol Res Pract; 2002; 198(7):449-54. PubMed ID: 12234063
[TBL] [Abstract][Full Text] [Related]
10. The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells.
Petitjean A; Cavard C; Shi H; Tribollet V; Hainaut P; Caron de Fromentel C
Oncogene; 2005 Jan; 24(3):512-9. PubMed ID: 15543231
[TBL] [Abstract][Full Text] [Related]
11. p63: oncogene or tumor suppressor?
Mills AA
Curr Opin Genet Dev; 2006 Feb; 16(1):38-44. PubMed ID: 16359856
[TBL] [Abstract][Full Text] [Related]
12. p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin.
Reis-Filho JS; Preto A; Soares P; Ricardo S; Cameselle-Teijeiro J; Sobrinho-Simões M
Mod Pathol; 2003 Jan; 16(1):43-8. PubMed ID: 12527712
[TBL] [Abstract][Full Text] [Related]
13. Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73.
Petitjean A; Ruptier C; Tribollet V; Hautefeuille A; Chardon F; Cavard C; Puisieux A; Hainaut P; Caron de Fromentel C
Carcinogenesis; 2008 Feb; 29(2):273-81. PubMed ID: 18048390
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of p63 in oral lichen planus and graft-vs.-host disease associated with oral inflammation.
Ebrahimi M; Wahlin YB; Coates PJ; Sjöström B; Nylander K
J Oral Pathol Med; 2006 Jan; 35(1):46-50. PubMed ID: 16393253
[TBL] [Abstract][Full Text] [Related]
15. p63: Molecular complexity in development and cancer.
Westfall MD; Pietenpol JA
Carcinogenesis; 2004 Jun; 25(6):857-64. PubMed ID: 15033906
[TBL] [Abstract][Full Text] [Related]
16. TA-p63-gamma regulates expression of DeltaN-p63 in a manner that is sensitive to p53.
Li N; Li H; Cherukuri P; Farzan S; Harmes DC; DiRenzo J
Oncogene; 2006 Apr; 25(16):2349-59. PubMed ID: 16331262
[TBL] [Abstract][Full Text] [Related]
17. A dominant negative form of p63 inhibits apoptosis in a p53-independent manner.
Lee HO; Lee JH; Choi E; Seol JY; Yun Y; Lee H
Biochem Biophys Res Commun; 2006 May; 344(1):166-72. PubMed ID: 16616891
[TBL] [Abstract][Full Text] [Related]
18. p63 and epithelial biology.
Barbieri CE; Pietenpol JA
Exp Cell Res; 2006 Apr; 312(6):695-706. PubMed ID: 16406339
[TBL] [Abstract][Full Text] [Related]
19. p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate.
Kunisaki R; Ikawa S; Maeda T; Nakazaki Y; Kurita R; Harata M; Shutoh Y; Bai YS; Soda Y; Tanabe T; Dohi T; Kato R; Ikawa Y; Asano S; Tani K
J Gene Med; 2006 Sep; 8(9):1121-30. PubMed ID: 16832836
[TBL] [Abstract][Full Text] [Related]
20. TAp63-dependent induction of growth differentiation factor 15 (GDF15) plays a critical role in the regulation of keratinocyte differentiation.
Ichikawa T; Suenaga Y; Koda T; Ozaki T; Nakagawara A
Oncogene; 2008 Jan; 27(4):409-20. PubMed ID: 17637746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]